The Intra-Articular Injection Instrument has been developed to overcome the difficulties of using a conventional syringe to inject into both large and small joints in treatment of arthritis and other joint conditions. Often when given with a conventional syringe these injections are not efficacious, because the doctor using the syringe failed to locate the intra-articular space or did not inject the appropriate volume of hyaluronic acid or other medicament into that space. Arthritis patients are thus obliged to endure multiple painful injections for a lifetime. The CompuFlo technology, in an independent animal study, has been successful in administering viscous hyaluronic acid and other medicaments into the intra-articular space in both small and large joints using its computer-controlled pressure sensing capabilities.
The intra-articular market is expected to reach $7 billion by 2015. In the U.S. alone, osteoarthritis affects 33 million patients and over 21 million patients in U.S. receive intra-articular injections.
Copyright 2017 Milestone Medical Inc. All Rights Reserved.